About us

Building the future of cell-specific cancer therapies

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.

A Proprietary Data Advantage

Allowing us to derive unique insights from our massive and fully-integrated dataset of over 15M tumor and healthy cells.

A Powerful Therapeutic Engine

Leveraging cellular genomics, antibody engineering, and computational biology to translate targets into therapeutics.

what we do

Cartography is a therapeutics company building a differentiated pipeline of antibody-based therapies more precise than existing therapies.



Single cell sequencing to document target expression across all relevant cell types.


Target selection based on tumor expression, off-target impact, and market dynamics.


Program definition based on likelihood of success and ideal patient population.


Antibody and binder design that optimizes for targeting single or paired targets.


mission and values

Building a next generation drug discovery engine to widen the world of treatable cancers. We’re bridging the world of immunology and computation, to build a smarter roadmap for cancer therapies.

Boldly ambitious,
laser focused

We set big goals, make a plan, and achieve them.


The better we communicate with each other, the better we will work together.


Throughout our values, we remember that patients are at the core of everything we do.

United we thrive

We maintain a culture of respect and kindness, where courtesy and consideration for others are fundamental.

Collective ownership

We hold ourselves and each other accountable by lending a hand to carry the load.

Join our team of pioneers

Expand the reach of next-generation cancer therapies by working with us to make them more precise, more effective and more accessible for patients everywhere.